You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

166 Results
Guidelines and Advice
Status: Current
ID: N/A
Version: Final
May 2018
Drug
Other Name(s): Folotyn®
Quick Link(s): Drug Monograph, Patient Info Sheet
Jan 2026
Guidelines and Advice
Status: In-Review
ID: ES 15-16
Oct 2018
Guidelines and Advice
Status: Current
ID: N/A
Version: 2.1
Sep 2021
Guidelines and Advice
Status: Current
Version: 2
Dec 2021
Regimen
Cancer Type:
Hematologic, 
Leukemia - Acute Myeloid (AML)
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative
Funding:
New Drug Funding Program
    Gemtuzumab Ozogamicin (Outpatient) - Previously Untreated Acute Myeloid Leukemia
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
DAUNOrubicin,
cytarabine,
gemtuzumab ozogamicin
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Nov 2021
Statistical Reports
Apr 2018
Statistical Reports
Apr 2018
Guidelines and Advice
Status: Current
Apr 2021
Guidelines and Advice
Status: Current
ID: ES 11-13
Feb 2021
Regimen
Cancer Type:
Sarcoma, 
Soft Tissue
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant, Curative
Drugs Used:
vinorelbine,
cyclophosphamide
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Feb 2021
Regimen
Cancer Type:
Hematologic, 
Lymphoma - T-cell, 
Rare Diseases
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Drugs Used:
pentostatin (Unfunded),
alemtuzumab (Compassionate)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Apr 2021

Pages